APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cell Therapy

Cell therapy (also called cellular therapy, cell transplantation, or cytotherapy) is a therapy in which viable cells are injected, grafted or implanted into a patient in order to effectuate a medicinal effect, for example, by transplanting T-cells capable of fighting cancer cells via cell-mediated immunity in the course of immunotherapy, or grafting stem cells to regenerate diseased tissues.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Cell therapy (also called cellular therapy, cell transplantation, or cytotherapy) is a therapy in which viable cells are injected, grafted or implanted into a patient in order to effectuate a medicinal effect, for example, by transplanting T-cells capable of fighting cancer cells via cell-mediated immunity in the course of immunotherapy, or grafting stem cells to regenerate diseased tissues.

Selected research

Market Structure

Global Cell Therapy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

31 December 2025197 pages

Choose your research edition.

Industry ResearchCell Therapy Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Cell Therapy Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Cell Therapy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cell Therapy Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Cell Therapy Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

Cell therapy (also called cellular therapy, cell transplantation, or cytotherapy) is a therapy in which viable cells are injected, grafted or implanted into a patient in order to effectuate a medicinal effect, for example, by transplanting T-cells capable of fighting cancer cells via cell-mediated immunity in the course of immunotherapy, or grafting stem cells to regenerate diseased tissues.

The classification of Cell Therapy includes Stem Cell therapy and Non-Stem Cell therapy, and the revenue proportion of Stem Cell therapy in 2019 is about 98.76%.

Cell Therapy is widely used in Hospital, Clinics and Other. The most proportion of Cell Therapy is Hospital, and the proportion in 2019 is about 77.2%.

Read the full market overview

North Americas is the largest consumption place, with a consumption market share nearly 43.65% in 2019. Following North Americas, Europe is the second largest consumption place with the consumption market share of 35.41%.

Report Includes

This report provides an overview of the global Cell Therapy market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Cell Therapy and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Cell Therapy revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Cell Therapy market size, projected growth trends, production technologies, key applications, and end-use industries.

Cell Therapy Segment by Company

Gilead Sciences

Novartis

Osiris

Vericel Corporation

Vcanbio

Fujifilm Cellular Dynamics

JCR Pharmaceuticals

Beike Biotechnology

Golden Meditech

Guanhao Biotech

Cell Therapy Segment by Type

Stem Cell

Non-Stem Cell

Cell Therapy Segment by Application

Hospital

Clinic

Cell Therapy Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cell Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cell Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cell Therapy.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Cell Therapy in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Cell Therapy industry.

Chapter 3: Detailed analysis of Cell Therapy companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cell Therapyrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Cell Therapy Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Stem Cell Table 3. Key Players of Non-Stem Cell Table 4. Global Cell Therapy Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Hospital Table 6. Key Players of Clinic Table 7. Global Cell Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 8. Global Cell Therapy Market Size by Region (2021-2026) & (US$ Million) Table 9. Global Cell Therapy Market Share by Region (2021-2026) Table 10. Global Cell Therapy Market Size by Region (2027-2032) & (US$ Million) Table 11. Global Cell Therapy Market Share by Region (2027-2032) Table 12. Cell Therapy Industry Trends Table 13. Cell Therapy Industry Drivers Table 14. Cell Therapy Industry Opportunities and Challenges Table 15. Cell Therapy Industry Restraints Table 16. Global Cell Therapy Revenue by Company (US$ Million) & (2021-2026) Table 17. Global Cell Therapy Revenue Market Share by Company (2021-2026) Table 18. Global Cell Therapy Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 19. Global Cell Therapy Key Company Head Office and Area Served Table 20. Global Cell Therapy Company, Product Type & Application Table 21. Global Cell Therapy Company Establishment Date Table 22. Global Company Market Concentration Ratio (CR5 and HHI) Table 23. Global Cell Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 24. Global Cell Therapy Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Cell Therapy Market Size by Type (2021-2026) & (US$ Million) Table 26. Global Cell Therapy Market Size by Type (2027-2032) & (US$ Million) Table 27. Global Cell Therapy Revenue Market Share by Type (2021-2026) Table 28. Global Cell Therapy Revenue Market Share by Type (2027-2032) Table 29. Global Cell Therapy Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Cell Therapy Market Size by Application (2021-2026) & (US$ Million) Table 31. Global Cell Therapy Market Size by Application (2027-2032) & (US$ Million) Table 32. Global Cell Therapy Revenue Market Share by Application (2021-2026) Table 33. Global Cell Therapy Revenue Market Share by Application (2027-2032) Table 34. Gilead Sciences Company Information Table 35. Gilead Sciences Business Overview Table 36. Gilead Sciences Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. Gilead Sciences Cell Therapy Product Portfolio Table 38. Gilead Sciences Recent Development Table 39. Novartis Company Information Table 40. Novartis Business Overview Table 41. Novartis Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Novartis Cell Therapy Product Portfolio Table 43. Novartis Recent Development Table 44. Osiris Company Information Table 45. Osiris Business Overview Table 46. Osiris Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Osiris Cell Therapy Product Portfolio Table 48. Osiris Recent Development Table 49. Vericel Corporation Company Information Table 50. Vericel Corporation Business Overview Table 51. Vericel Corporation Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Vericel Corporation Cell Therapy Product Portfolio Table 53. Vericel Corporation Recent Development Table 54. Vcanbio Company Information Table 55. Vcanbio Business Overview Table 56. Vcanbio Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Vcanbio Cell Therapy Product Portfolio Table 58. Vcanbio Recent Development Table 59. Fujifilm Cellular Dynamics Company Information Table 60. Fujifilm Cellular Dynamics Business Overview Table 61. Fujifilm Cellular Dynamics Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Fujifilm Cellular Dynamics Cell Therapy Product Portfolio Table 63. Fujifilm Cellular Dynamics Recent Development Table 64. JCR Pharmaceuticals Company Information Table 65. JCR Pharmaceuticals Business Overview Table 66. JCR Pharmaceuticals Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. JCR Pharmaceuticals Cell Therapy Product Portfolio Table 68. JCR Pharmaceuticals Recent Development Table 69. Beike Biotechnology Company Information Table 70. Beike Biotechnology Business Overview Table 71. Beike Biotechnology Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Beike Biotechnology Cell Therapy Product Portfolio Table 73. Beike Biotechnology Recent Development Table 74. Golden Meditech Company Information Table 75. Golden Meditech Business Overview Table 76. Golden Meditech Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. Golden Meditech Cell Therapy Product Portfolio Table 78. Golden Meditech Recent Development Table 79. Guanhao Biotech Company Information Table 80. Guanhao Biotech Business Overview Table 81. Guanhao Biotech Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. Guanhao Biotech Cell Therapy Product Portfolio Table 83. Guanhao Biotech Recent Development Table 84. North America Cell Therapy Market Size by Type (2021-2026) & (US$ Million) Table 85. North America Cell Therapy Market Size by Type (2027-2032) & (US$ Million) Table 86. North America Cell Therapy Market Size by Application (2021-2026) & (US$ Million) Table 87. North America Cell Therapy Market Size by Application (2027-2032) & (US$ Million) Table 88. North America Cell Therapy Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 89. North America Cell Therapy Market Size by Country (2021-2026) Table 90. North America Cell Therapy Market Size by Country (2027-2032) Table 91. Europe Cell Therapy Market Size by Type (2021-2026) & (US$ Million) Table 92. Europe Cell Therapy Market Size by Type (2027-2032) & (US$ Million) Table 93. Europe Cell Therapy Market Size by Application (2021-2026) & (US$ Million) Table 94. Europe Cell Therapy Market Size by Application (2027-2032) & (US$ Million) Table 95. Europe Cell Therapy Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 96. Europe Cell Therapy Market Size by Country (2021-2026) Table 97. Europe Cell Therapy Market Size by Country (2027-2032) Table 98. China Cell Therapy Market Size by Type (2021-2026) & (US$ Million) Table 99. China Cell Therapy Market Size by Type (2027-2032) & (US$ Million) Table 100. China Cell Therapy Market Size by Application (2021-2026) & (US$ Million) Table 101. China Cell Therapy Market Size by Application (2027-2032) & (US$ Million) Table 102. Asia Cell Therapy Market Size by Type (2021-2026) & (US$ Million) Table 103. Asia Cell Therapy Market Size by Type (2027-2032) & (US$ Million) Table 104. Asia Cell Therapy Market Size by Application (2021-2026) & (US$ Million) Table 105. Asia Cell Therapy Market Size by Application (2027-2032) & (US$ Million) Table 106. Asia Cell Therapy Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 107. Asia Cell Therapy Market Size by Country (2021-2026) Table 108. Asia Cell Therapy Market Size by Country (2027-2032) Table 109. South America, Middle East & Africa Cell Therapy Market Size by Type (2021-2026) & (US$ Million) Table 110. South America, Middle East & Africa Cell Therapy Market Size by Type (2027-2032) & (US$ Million) Table 111. South America, Middle East & Africa Cell Therapy Market Size by Application (2021-2026) & (US$ Million) Table 112. South America, Middle East & Africa Cell Therapy Market Size by Application (2027-2032) & (US$ Million) Table 113. South America, Middle East & Africa Cell Therapy Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 114. South America, Middle East & Africa Cell Therapy Market Size by Country (2021-2026) Table 115. South America, Middle East & Africa Cell Therapy Market Size by Country (2027-2032) Table 116. Research Programs/Design for This Report Table 117. Authors List of This Report Table 118. Secondary Sources Table 119. Primary Sources List of Figures Figure 1. Cell Therapy Product Image Figure 2. Global Cell Therapy Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Cell Therapy Market Share by Type: 2025 VS 2032 Figure 4. Stem Cell Image Figure 5. Non-Stem Cell Image Figure 6. Global Cell Therapy Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 7. Global Cell Therapy Market Share by Application: 2025 VS 2032 Figure 8. Hospital Image Figure 9. Clinic Image Figure 10. Global Cell Therapy Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 12. Global Cell Therapy Market Share by Region: 2025 VS 2032 Figure 13. Years Considered Figure 14. Global Cell Therapy Market Share by Players in 2025 Figure 15. Global Top 5 and 10 Cell Therapy Players Market Share by Revenue in 2025 Figure 16. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Cell Therapy Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Cell Therapy Revenue Market Share by Type (2021-2032) Figure 19. Global Cell Therapy Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Cell Therapy Revenue Market Share by Application (2021-2032) Figure 21. North America Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 22. North America Cell Therapy Market Share by Type (2021-2032) Figure 23. North America Cell Therapy Market Share by Application (2021-2032) Figure 24. North America Cell Therapy Market Share by Country (2021-2032) Figure 25. United States Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 26. Canada Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 27. Mexico Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 28. Europe Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 29. Europe Cell Therapy Market Share by Type (2021-2032) Figure 30. Europe Cell Therapy Market Share by Application (2021-2032) Figure 31. Europe Cell Therapy Market Share by Country (2021-2032) Figure 32. Germany Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 33. France Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 34. U.K. Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 35. Italy Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 36. Russia Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 37. Nordic Countries Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 38. China Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 39. China Cell Therapy Market Share by Type (2021-2032) Figure 40. China Cell Therapy Market Share by Application (2021-2032) Figure 41. Asia Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 42. Asia Cell Therapy Market Share by Type (2021-2032) Figure 43. Asia Cell Therapy Market Share by Application (2021-2032) Figure 44. Asia Cell Therapy Market Share by Country (2021-2032) Figure 45. Japan Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 46. South Korea Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 47. Taiwan Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 48. Southeast Asia Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 49. India Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 50. Australia Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 51. South America, Middle East & Africa Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 52. South America, Middle East & Africa Cell Therapy Market Share by Type (2021-2032) Figure 53. South America, Middle East & Africa Cell Therapy Market Share by Application (2021-2032) Figure 54. South America, Middle East & Africa Cell Therapy Market Share by Country (2021-2032) Figure 55. Brazil Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 56. South Africa Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 57. Saudi Arabia Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 58. Turkey Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 59. Argentina Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 60. UAE Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 61. Egypt Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 62. Chile Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 63. Research Process Figure 64. Key Executives Interviewed

Scope & coverage.

Types
  • Stem Cell
  • Non-Stem Cell
Applications
  • Hospital
  • Clinic
Companies covered
  • Gilead Sciences
  • Novartis
  • Osiris
  • Vericel Corporation
  • Vcanbio
  • Fujifilm Cellular Dynamics
  • JCR Pharmaceuticals
  • Beike Biotechnology
  • Golden Meditech
  • Guanhao Biotech

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Cell Therapy Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Stem Cell
  5. 1.2.3 Non-Stem Cell
  6. 1.3 Market Analysis by Application
  7. 1.3.1 Global Cell Therapy Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Clinic
  10. 1.4 Global Market Growth Prospects
  11. 1.5 Global Cell Therapy Growth Trends by Region
  12. 1.5.1 Global Cell Therapy Market Size by Region: 2021 VS 2025 VS 2032
  13. 1.5.2 Cell Therapy Market Size by Region (2021-2026)
  14. 1.5.3 Cell Therapy Market Size by Region (2027-2032)
  15. 1.6 Assumptions and Limitations
  16. 1.7 Study Goals and Objectives
  17. 1.8 Years Considered
2 Global Cell Therapy Market Dynamics
  1. 2.1 Cell Therapy Industry Trends
  2. 2.2 Cell Therapy Industry Drivers
  3. 2.3 Cell Therapy Industry Opportunities and Challenges
  4. 2.4 Cell Therapy Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Cell Therapy Revenue by Company (2021-2026)
  2. 3.2 Global Cell Therapy Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Cell Therapy Key Company Head office and Area Served
  4. 3.4 Global Cell Therapy Company, Product Type & Application
  5. 3.5 Global Cell Therapy Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Cell Therapy Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Cell Therapy Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Cell Therapy Tier 1, Tier 2, and Tier 3
4 Cell Therapy Market by Type
  1. 4.1 Global Cell Therapy Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Cell Therapy Market Size by Type (2021-2032)
  3. 4.3 Global Cell Therapy Market Size Share by Type (2021-2032)
5 Cell Therapy Market by Application
  1. 5.1 Global Cell Therapy Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Cell Therapy Market Size by Application (2021-2032)
  3. 5.3 Global Cell Therapy Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Gilead Sciences
  2. 6.1.1 Gilead Sciences Company Information
  3. 6.1.2 Gilead Sciences Business Overview
  4. 6.1.3 Gilead Sciences Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Gilead Sciences Cell Therapy Product Portfolio
  6. 6.1.5 Gilead Sciences Recent Developments
  7. 6.2 Novartis
  8. 6.2.1 Novartis Company Information
  9. 6.2.2 Novartis Business Overview
  10. 6.2.3 Novartis Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Novartis Cell Therapy Product Portfolio
  12. 6.2.5 Novartis Recent Developments
  13. 6.3 Osiris
  14. 6.3.1 Osiris Company Information
  15. 6.3.2 Osiris Business Overview
  16. 6.3.3 Osiris Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Osiris Cell Therapy Product Portfolio
  18. 6.3.5 Osiris Recent Developments
  19. 6.4 Vericel Corporation
  20. 6.4.1 Vericel Corporation Company Information
  21. 6.4.2 Vericel Corporation Business Overview
  22. 6.4.3 Vericel Corporation Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Vericel Corporation Cell Therapy Product Portfolio
  24. 6.4.5 Vericel Corporation Recent Developments
  25. 6.5 Vcanbio
  26. 6.5.1 Vcanbio Company Information
  27. 6.5.2 Vcanbio Business Overview
  28. 6.5.3 Vcanbio Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Vcanbio Cell Therapy Product Portfolio
  30. 6.5.5 Vcanbio Recent Developments
  31. 6.6 Fujifilm Cellular Dynamics
  32. 6.6.1 Fujifilm Cellular Dynamics Company Information
  33. 6.6.2 Fujifilm Cellular Dynamics Business Overview
  34. 6.6.3 Fujifilm Cellular Dynamics Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Fujifilm Cellular Dynamics Cell Therapy Product Portfolio
  36. 6.6.5 Fujifilm Cellular Dynamics Recent Developments
  37. 6.7 JCR Pharmaceuticals
  38. 6.7.1 JCR Pharmaceuticals Company Information
  39. 6.7.2 JCR Pharmaceuticals Business Overview
  40. 6.7.3 JCR Pharmaceuticals Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 JCR Pharmaceuticals Cell Therapy Product Portfolio
  42. 6.7.5 JCR Pharmaceuticals Recent Developments
  43. 6.8 Beike Biotechnology
  44. 6.8.1 Beike Biotechnology Company Information
  45. 6.8.2 Beike Biotechnology Business Overview
  46. 6.8.3 Beike Biotechnology Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Beike Biotechnology Cell Therapy Product Portfolio
  48. 6.8.5 Beike Biotechnology Recent Developments
  49. 6.9 Golden Meditech
  50. 6.9.1 Golden Meditech Company Information
  51. 6.9.2 Golden Meditech Business Overview
  52. 6.9.3 Golden Meditech Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Golden Meditech Cell Therapy Product Portfolio
  54. 6.9.5 Golden Meditech Recent Developments
  55. 6.10 Guanhao Biotech
  56. 6.10.1 Guanhao Biotech Company Information
  57. 6.10.2 Guanhao Biotech Business Overview
  58. 6.10.3 Guanhao Biotech Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Guanhao Biotech Cell Therapy Product Portfolio
  60. 6.10.5 Guanhao Biotech Recent Developments
7 North America
  1. 7.1 North America Cell Therapy Market Size (2021-2032)
  2. 7.2 North America Cell Therapy Market Size by Type
  3. 7.2.1 North America Cell Therapy Market Size by Type (2021-2026)
  4. 7.2.2 North America Cell Therapy Market Size by Type (2027-2032)
  5. 7.2.3 North America Cell Therapy Market Share by Type (2021-2032)
  6. 7.3 North America Cell Therapy Market Size by Application
  7. 7.3.1 North America Cell Therapy Market Size by Application (2021-2026)
  8. 7.3.2 North America Cell Therapy Market Size by Application (2027-2032)
  9. 7.3.3 North America Cell Therapy Market Share by Application (2021-2032)
  10. 7.4 North America Cell Therapy Market Size by Country
  11. 7.4.1 North America Cell Therapy Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Cell Therapy Market Size by Country (2021-2026)
  13. 7.4.3 North America Cell Therapy Market Size by Country (2027-2032)
  14. 7.4.4 North America Cell Therapy Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Cell Therapy Market Size (2021-2032)
  2. 8.2 Europe Cell Therapy Market Size by Type
  3. 8.2.1 Europe Cell Therapy Market Size by Type (2021-2026)
  4. 8.2.2 Europe Cell Therapy Market Size by Type (2027-2032)
  5. 8.2.3 Europe Cell Therapy Market Share by Type (2021-2032)
  6. 8.3 Europe Cell Therapy Market Size by Application
  7. 8.3.1 Europe Cell Therapy Market Size by Application (2021-2026)
  8. 8.3.2 Europe Cell Therapy Market Size by Application (2027-2032)
  9. 8.3.3 Europe Cell Therapy Market Share by Application (2021-2032)
  10. 8.4 Europe Cell Therapy Market Size by Country
  11. 8.4.1 Europe Cell Therapy Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Cell Therapy Market Size by Country (2021-2026)
  13. 8.4.3 Europe Cell Therapy Market Size by Country (2027-2032)
  14. 8.4.4 Europe Cell Therapy Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Cell Therapy Market Size (2021-2032)
  2. 9.2 China Cell Therapy Market Size by Type
  3. 9.2.1 China Cell Therapy Market Size by Type (2021-2026)
  4. 9.2.2 China Cell Therapy Market Size by Type (2027-2032)
  5. 9.2.3 China Cell Therapy Market Share by Type (2021-2032)
  6. 9.3 China Cell Therapy Market Size by Application
  7. 9.3.1 China Cell Therapy Market Size by Application (2021-2026)
  8. 9.3.2 China Cell Therapy Market Size by Application (2027-2032)
  9. 9.3.3 China Cell Therapy Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Cell Therapy Market Size (2021-2032)
  2. 10.2 Asia Cell Therapy Market Size by Type
  3. 10.2.1 Asia Cell Therapy Market Size by Type (2021-2026)
  4. 10.2.2 Asia Cell Therapy Market Size by Type (2027-2032)
  5. 10.2.3 Asia Cell Therapy Market Share by Type (2021-2032)
  6. 10.3 Asia Cell Therapy Market Size by Application
  7. 10.3.1 Asia Cell Therapy Market Size by Application (2021-2026)
  8. 10.3.2 Asia Cell Therapy Market Size by Application (2027-2032)
  9. 10.3.3 Asia Cell Therapy Market Share by Application (2021-2032)
  10. 10.4 Asia Cell Therapy Market Size by Country
  11. 10.4.1 Asia Cell Therapy Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Cell Therapy Market Size by Country (2021-2026)
  13. 10.4.3 Asia Cell Therapy Market Size by Country (2027-2032)
  14. 10.4.4 Asia Cell Therapy Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Cell Therapy Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Cell Therapy Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Cell Therapy Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Cell Therapy Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Cell Therapy Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Cell Therapy Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Cell Therapy Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Cell Therapy Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Cell Therapy Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Cell Therapy Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Cell Therapy Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Cell Therapy Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Cell Therapy Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Cell Therapy Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst